Moderate Alcohol Consumption and Chronic Disease: The Case for a Long-Term Trial - PubMed (original) (raw)

Review

. 2016 Nov;40(11):2283-2291.

doi: 10.1111/acer.13231. Epub 2016 Sep 30.

Affiliations

Review

Moderate Alcohol Consumption and Chronic Disease: The Case for a Long-Term Trial

Kenneth J Mukamal et al. Alcohol Clin Exp Res. 2016 Nov.

Abstract

Drinking within recommended limits is highly prevalent in much of the world, and strong epidemiological associations exist between moderate alcohol consumption and risk of several major chronic diseases, including coronary heart disease, diabetes, and breast cancer. In many cases, plausible biological mediators for these associations have been identified in randomized trials, but gold standard evidence that moderate drinking causes or prevents any chronic disease remains elusive and important concerns about available evidence have been raised. Although long-term randomized trials to test the observed associations have been termed impossible, clinical investigators have now successfully completed randomized trials of complex nutritional interventions in a variety of settings, along with trials of alcohol consumption itself of up to 2 years duration. The successful completion of these trials suggests that objections to the execution of a full-scale, long-term clinical trial of moderate drinking on chronic disease are increasingly untenable. We present potential lessons learned for such a trial and discuss key features to maximize its feasibility and value.

Keywords: Feeding Studies; Randomized Controlled Trial.

Copyright © 2016 by the Research Society on Alcoholism.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Proposed associations of moderate alcohol consumption with chronic disease.

References

    1. Global Status Report on Alcohol and Health. World Health Organization; Geneva: 2014.
    1. SERVICES, D. O. H. A. H., editor. Announcement of Requirements and Registration for “A Wearable Alcohol Biosensor” Challenge. Washington, D.C.: 2015.
    1. ANDERSEN MB, KRISTENSEN M, MANACH C, PUJOS-GUILLOT E, POULSEN SK, LARSEN TM, ASTRUP A, DRAGSTED L. Discovery and validation of urinary exposure markers for different plant foods by untargeted metabolomics. Anal Bioanal Chem. 2014;406:1829–44. - PubMed
    1. ANSARY-MOGHADDAM A, HUXLEY RR, LAM TH, WOODWARD M. The risk of upper aero digestive tract cancer associated with smoking, with and without concurrent alcohol consumption. Mt Sinai J Med. 2009;76:392–403. - PubMed
    1. BERESFORD SA, JOHNSON KC, RITENBAUGH C, LASSER NL, SNETSELAAR LG, BLACK HR, ANDERSON GL, ASSAF AR, BASSFORD T, BOWEN D, BRUNNER RL, BRZYSKI RG, CAAN B, CHLEBOWSKI RT, GASS M, HARRIGAN RC, HAYS J, HEBER D, HEISS G, HENDRIX SL, HOWARD BV, HSIA J, HUBBELL FA, JACKSON RD, KOTCHEN JM, KULLER LH, LACROIX AZ, LANE DS, LANGER RD, LEWIS CE, MANSON JE, MARGOLIS KL, MOSSAVAR-RAHMANI Y, OCKENE JK, PARKER LM, PERRI MG, PHILLIPS L, PRENTICE RL, ROBBINS J, ROSSOUW JE, SARTO GE, STEFANICK ML, VAN HORN L, VITOLINS MZ, WACTAWSKI-WENDE J, WALLACE RB, WHITLOCK E. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295:643–54. - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources